Showing results (571-580 of 620) with videos related to
Sort By:
Pageof 62
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2022
Measurement of Severe Acute Respiratory Syndrome Coronavirus 2 Antigens in Plasma of Pediatric Patients With Acute Coronavirus Disease 2019 or Multisystem Inflammatory Syndrome in Children Using an Ultrasensitive and Quantitative ImmunoassayGeorge B Sigal, Tanya Novak, Anu Mathew, et al.The Pediatric Infectious Disease Journal|March 31, 2023
Risk Factors for Multisystem Inflammatory Syndrome in Children: A Case-control InvestigationLaura D Zambrano, Michael J Wu, Lora Martin, et al.American Journal of Obstetrics & Gynecology MFM|January 20, 2023
Outcomes of shared institutional review board compared with multiple individual site institutional review board models in a multisite clinical trialSamantha L Martin, Phillip H Allman, Lorraine Dugoff, et al.Nature Biotechnology|November 20, 2019
Harnessing type I CRISPR-Cas systems for genome engineering in human cellsPeter Cameron, Mary M Coons, Sanne E Klompe, et al.Cancer Immunology Research|February 12, 2024
High-Specificity CRISPR-Mediated Genome Engineering in Anti-BCMA Allogeneic CAR T Cells Suppresses Allograft Rejection in Preclinical ModelsÉmilie Degagné, Paul D Donohoue, Suparna Roy, et al.The Pediatric Infectious Disease Journal|December 27, 2021
Frequency, Characteristics and Complications of COVID-19 in Hospitalized InfantsCharlotte V Hobbs, Kate Woodworth, Cameron C Young, et al.MMWR. Morbidity and Mortality Weekly Report|October 21, 2021
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021Samantha M Olson, Margaret M Newhams, Natasha B Halasa, et al.The CRISPR Journal|February 14, 2024
Generation of a Commercial-Scale Founder Population of Porcine Reproductive and Respiratory Syndrome Virus Resistant Pigs Using CRISPR-CasBrian T Burger, Benjamin P Beaton, Matthew A Campbell, et al.Contemporary Clinical Trials|December 28, 2022
Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experienceAngelique E Boutzoukas, Rachel Olson, Mary Ann Sellers, et al.MMWR. Morbidity and Mortality Weekly Report|January 13, 2022
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021Laura D Zambrano, Margaret M Newhams, Samantha M Olson, et al.Pageof 62